IRIS Institutional Research Information System - OPENBS Open Archive UniBS

VITA, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 27.735
AS - Asia 12.753
EU - Europa 9.939
SA - Sud America 2.473
Continente sconosciuto - Info sul continente non disponibili 853
AF - Africa 303
OC - Oceania 50
Totale 54.106
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 26.955
SG - Singapore 4.545
CN - Cina 4.140
IT - Italia 2.875
UA - Ucraina 2.032
BR - Brasile 2.024
HK - Hong Kong 1.496
DE - Germania 1.105
FR - Francia 720
GB - Regno Unito 642
VN - Vietnam 625
FI - Finlandia 546
TR - Turchia 464
RU - Federazione Russa 454
BD - Bangladesh 427
CA - Canada 401
PL - Polonia 397
IE - Irlanda 395
IN - India 336
MX - Messico 153
SE - Svezia 151
AR - Argentina 149
NL - Olanda 118
CZ - Repubblica Ceca 109
ID - Indonesia 94
ZA - Sudafrica 94
IQ - Iraq 93
JP - Giappone 93
ES - Italia 72
CO - Colombia 71
EC - Ecuador 69
SA - Arabia Saudita 62
VE - Venezuela 57
BE - Belgio 53
PK - Pakistan 50
AT - Austria 49
AU - Australia 48
UZ - Uzbekistan 46
NG - Nigeria 43
JM - Giamaica 36
CR - Costa Rica 35
LT - Lituania 35
PY - Paraguay 33
CH - Svizzera 32
MA - Marocco 32
IR - Iran 31
EU - Europa 29
EG - Egitto 26
KE - Kenya 25
TT - Trinidad e Tobago 25
CL - Cile 24
HN - Honduras 24
PH - Filippine 24
IL - Israele 22
PE - Perù 22
MY - Malesia 20
AL - Albania 19
NP - Nepal 19
TN - Tunisia 19
ET - Etiopia 17
GR - Grecia 17
GT - Guatemala 17
JO - Giordania 17
AE - Emirati Arabi Uniti 16
PT - Portogallo 16
SV - El Salvador 16
AZ - Azerbaigian 15
DZ - Algeria 15
HU - Ungheria 14
KR - Corea 14
NI - Nicaragua 13
PR - Porto Rico 13
UY - Uruguay 13
BG - Bulgaria 12
KZ - Kazakistan 12
RO - Romania 12
KG - Kirghizistan 11
CW - ???statistics.table.value.countryCode.CW??? 10
DK - Danimarca 10
EE - Estonia 10
LB - Libano 10
PS - Palestinian Territory 10
TH - Thailandia 10
BB - Barbados 9
DO - Repubblica Dominicana 9
OM - Oman 9
BO - Bolivia 8
CI - Costa d'Avorio 8
PA - Panama 8
AM - Armenia 7
BY - Bielorussia 7
LV - Lettonia 7
NO - Norvegia 6
SN - Senegal 6
A1 - Anonimo 5
BH - Bahrain 5
GP - Guadalupe 5
MU - Mauritius 5
SY - Repubblica araba siriana 5
LK - Sri Lanka 4
Totale 53.218
Salva come PNG Salva come JPEG
Città #
Ashburn 2.650
Singapore 2.460
Fairfield 2.179
Woodbridge 1.786
Jacksonville 1.543
Hong Kong 1.483
Houston 1.344
San Jose 1.344
Chandler 1.119
The Dalles 958
Council Bluffs 953
Seattle 873
Cambridge 856
Ann Arbor 807
Wilmington 788
Beijing 778
Princeton 725
New York 689
Nanjing 517
Los Angeles 451
Lauterbourg 400
Dublin 390
Brescia 385
Warsaw 384
Istanbul 374
Milan 339
Helsinki 332
Dallas 307
Columbus 243
Munich 230
Ho Chi Minh City 221
São Paulo 218
Santa Clara 193
Des Moines 189
Nanchang 185
Buffalo 179
Redondo Beach 174
Rome 170
Changsha 164
Moscow 164
Chicago 159
Dearborn 155
Boardman 144
Shenyang 138
Tianjin 133
Lancaster 132
Jinan 127
Hebei 124
Hanoi 123
Shanghai 122
Toronto 120
San Diego 117
San Francisco 115
Phoenix 103
Orem 100
London 96
Brooklyn 86
Hangzhou 83
Frankfurt am Main 80
Jiaxing 80
Tokyo 78
Atlanta 73
Montreal 72
Brno 71
North Bergen 68
Mexico City 67
Naples 66
Turku 63
Zhengzhou 62
Denver 60
Romola 60
Guangzhou 58
Rio de Janeiro 57
Turin 55
Washington 55
Belo Horizonte 54
Kunming 54
Nuremberg 51
San Mateo 50
Johannesburg 48
Chennai 46
Tashkent 45
Stockholm 43
Manchester 41
Abuja 40
Jakarta 40
Salt Lake City 39
Boston 38
Brasília 38
Augusta 37
Brussels 37
Charlotte 36
Amsterdam 35
Verona 35
Lanzhou 34
Newark 34
Ningbo 34
Norwalk 34
Mumbai 33
Paris 32
Totale 33.854
Salva come PNG Salva come JPEG
Nome #
Cognitive Remediation Therapy (CRT): presupposti e descrizione. 498
Exome sequencing in schizophrenic patients with high levels of homozygosity identifies novel and extremely rare mutations in the GABA/glutamatergic pathways 334
The Effect of Antipsychotic Treatment on Cortical Gray Matter Changes in Schizophrenia: Does the Class Matter? A Meta-analysis and Meta-regression of Longitudinal Magnetic Resonance Imaging Studies 295
Il training cognitivo nei pazienti affetti da schizofrenia 284
The impairment of GABAergic pathway as one of the driver forces in the etiopathogenesis of schizophrenia: evidence from functional studies and gene-set enrichment analyses 251
Predictors of cognitive improvement and normalization under cognitive remediation in patients with schizophrenia. 244
Italian Study on Depressive Disorders (STudio Italiano MAlattia Depressiva, or STIMA-D): a nationwide snapshot of the status of treatment for major depression. 225
A novel homozygous mutation in GAD1 gene described in a schizophrenic patient impairs activity and dimerization of GAD67 enzyme 222
Autism spectrum disorder and schizophrenia: Do they overlap? 219
Cognitive remediation in schizophrenia: current status and future perspectives. 212
The patient journey project in Italian mental health services: results from a co-designed survey on clinical interventions and current barriers to improve the care of people living with schizophrenia 211
Looking through autistic features in schizophrenia using the PANSS Autism Severity Score (PAUSS) 210
Adult ADHD: Prevalence and Clinical Correlates in a Sample of Italian Psychiatric Outpatients 207
Autistic traits in a sample of adult patients with schizophrenia: prevalence and correlates 206
Correlates of autistic traits among patients with borderline personality disorder 202
A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder. 201
Psychomotor agitation in subjects hospitalized for an acute exacerbation of Schizophrenia 200
Combined measure of smooth pursuit eye movements and ventricle-brain ratio in schizophrenic disorders. 198
Adult Autism Subthreshold Spectrum (AdAS Spectrum): Validation of a questionnaire investigating subthreshold autism spectrum 197
Factors Associated With Response and Resistance to Cognitive Remediation in Schizophrenia: A Critical Review 197
Effectiveness, Core Elements, and Moderators of Response of Cognitive Remediation for Schizophrenia: A Systematic Review and Meta-analysis of Randomized Clinical Trials 196
Effectiveness of different modalities of cognitive remediation on symptomatological, neuropsychological, and functional outcome domains in schizophrenia: A prospective study in a real-world setting 193
Interview-based assessment of cognition in schizophrenia: applicability of the Schizophrenia Cognition Rating Scale (SCoRS) in different phases of illness and settings of care. 193
The influence of illness-related variables, personal resources and context-related factors on real-life functioning of people with schizophrenia 191
Antipsychotic drugs v. barbiturates or benzodiazepines used as active placebos for schizophrenia: a systematic review and meta-analysis 189
Effectiveness of Cognitive Remediation in Early Versus Chronic Schizophrenia: A Preliminary Report 186
Does cognitive remediation modify the use of psychiatric services and the patterns of care of patients with schizophrenia? 185
Risk and protective factors associated with mental health status in an Italian sample of students during the fourth wave of COVID-19 pandemic 184
X-linked mental retardation with Marfanoid habitus. First report of four italian patients. 184
A roadmap to disentangle the molecular etiology of schizophrenia 182
Lack of evidence for linkage to chromosomes 13 and 8 for schizophrenia and schizoaffective disorder 182
A linkage study of schizophrenia to markers within Xp11 near the MAOB gene. 182
Cognitive remediation in schizophrenia. 181
Psychiatric hospitalization rates in italy before and during covid-19: Did they change? an analysis of register data 180
Categorical and dimensional approaches to negative symptoms of schizophrenia: focus on long-term stability and functional outcome. 178
Effects of cognitive remediation therapy on neurocognition and negative symptoms in schizophrenia: an Italian naturalistic study 178
Autistic symptoms predict social cognitive performance in patients with schizophrenia 178
Brain structural abnormalities at the onset of schizophrenia and bipolar disorder: a meta-analysis of controlled magnetic resonance imaging studies 176
Translation and Validation of Italian Version of Index of Dental Anxiety and Fear (IDAF-4C+): A Cross-Sectional Study 176
Interventi non farmacologici nelle fasi precoci della schizofrenia: focus sul rimedio cognitivo. Non-pharmacological interventions in early schizophrenia: focus on cognitive remediation 174
At-risk gambling in patients with severe mental illness. Prevalence and associated features. 173
Alpha reactivity in schizophrenia and in schizophrenic spectrum disorders: demographic, clinical and hemispheric assessment. 172
Prevalence and Characteristics of Chemsex: A Cross-Sectional Observational Study 171
The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis 170
Psychopharmacological treatment of cognitive deficits in Schizophrenia and mood disorders 170
Autistic Symptoms in Schizophrenia: Impact on Internalized Stigma, Well-Being, Clinical and Functional Characteristics 169
Developmental brain abnormalities in schizophrenia: contributions of genetic and perinatal factors. 168
Well-being in patients with schizophrenia, mood and personality disorders attending psychiatric services in the community. A controlled study 168
Neurobiological and clinical effect of metacognitive interpersonal therapy vs structured clinical model: study protocol for a randomized controlled trial 168
A reconsideration of the relationship between cerebral structural abnormalities and family history of schizophrenia. 167
Cognitive remediation in the early course of schizophrenia: a critical review. 167
Antipsychotics, antidepressants, anticonvulsants, and placebo on symptom dimensions of borderline personality disorder: a meta-analysis of randomized controlled and open-label trials 166
Psychopathologic, neuropsychological and functional outcome measures during cognitive rehabilitation in schizophrenia: A prospective controlled study in a real-world setting. 166
Adherence to antipsychotics in schizophrenia. 166
Brain structural effects of antidepressant treatment in major depression 166
Factors Associated With Brain Heterogeneity in Schizophrenia 166
Adult ADHD and sleep disorders: Prevalence, severity and predictors of sleep disorders in a sample of Italian psychiatric outpatients 166
Persistence of effectiveness of cognitive remediation interventions in schizophrenia: A 1-year follow-up study. 165
A genome-wide search for schizophrenia susceptibility genes. 164
Tools for measuring clinical effectiveness. 163
Virological and immunological study of schizophrenic patients in relation to CT scan abnormality. 163
Cognitive impairment after recovery from COVID-19: Frequency, profile, and relationships with clinical and laboratory indices 162
Evidence for linkage to psychosis and cerebral asymmetry (relative hand skill) on the X chromosome 162
Brain morphology in schizophrenic disorder: prevalence and correlates of diffuse (cortical and subcortical) brain atrophy. 162
Cognitive remediation in schizophrenia: a controlled study 162
Attitudes of Italian Psychiatrists Toward the Evaluation of Physical Comorbidities and Sexual Dysfunction in Patients With Schizophrenia. Implications for Clinical Practice 162
Neuropsychological features in patients with severe mental disorders and risk of violence: A prospective multicenter study in Italy 162
Impact of Physical Exercise Alone or in Combination with Cognitive Remediation on Cognitive Functions in People with Schizophrenia: A Qualitative Critical Review 160
The relationships of personal resources with symptom severity and psychosocial functioning in persons with schizophrenia: results from the Italian Network for Research on Psychoses study 160
Progressive loss of cortical gray matter in schizophrenia: a meta-analysis and meta-regression of longitudinal MRI studies. 157
Hyperprolactinemia in antipsychotic-naive patients with first-episode psychosis. 157
Additional Support for Schizophrenia Linkage on Chromosomes 6 and 8: A Multicenter Study 157
Catatonia Spectrum: Validation of a Questionnaire Investigating Catatonia Spectrum 156
Factors related to different reasons for antipsychotic drug discontinuation in the treatment of schizophrenia: A naturalistic 18-month follow-up study. 156
New Strategies to Improve Cognitive Symptom Domain in the Treatment of Schizophrenia 155
Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates 154
Disturbi psichici perinatali:focus sulla depressione post partum. 153
Cognitive Remediation Therapy (CRT): presupposti e descrizione. 153
Personal resources and depression in schizophrenia: The role of self-esteem, resilience and internalized stigma 153
Age of onset in familial schizophrenia. 152
Factors affecting antipsychotic drug discontinuation in the treatment of schizophrenia: Evidence from a naturalistic, retrospective, 18-month follow-up study. 152
Fertility and marital status in mood disorders: relationship with age at onset. 151
The interplay among nonsuicidal self-injury, depression, loneliness, resilience, and family relationships in youth: A path analysis 150
Patterns of Structural MRI Abnormalities in Deficit and Nondeficit Schizophrenia. 150
CT scan abnormalities and outcome of chronic schizophrenia 150
HLA-DR antigens in schizophrenia. 150
Season of birth and cerebral ventricular enlargement in schizophrenia 150
A meta-analysis of quantitative magnetic resonance imaging study in first-episode schizophrenia. 150
Treatment satisfaction and effectiveness of Lurasidone on quality of life and functioning in adult patients with schizophrenia in the real-world Italian clinical practice: a prospective 3-month observational study 149
Longitudinal studies of brain morphology and outcome of schizophrenic disorder 149
COMT Val(158)Met and BDNF C(270)T polymorphisms in schizophrenia: a case-control study. 148
Cognitive remediation in schizophrenia: background, techniques, evidence of efficacy and perspectives 148
Non pharmacological strategies to enhance adherence and continuity of care in schizophrenia. 148
Negative symptom severity at discharge from an index hospitalization and subsequent use of psychiatric care resources: A retrospective 1-year follow-up study on 450 patients with schizophrenia spectrum disorders 148
Post-traumatic stress disorder and subthreshold post-traumatic stress disorder in recent male asylum seekers: An expected but overlooked “European” epidemic 147
Improving depressive symptoms in patients with schizophrenia using bilateral bipolar-nonbalanced prefrontal tDCS: Results from a double-blind sham-controlled trial 146
Il training cognitivo della Terapia Psicologica Integrata (IPT): presupposti e descrizione. 146
Gray matter, white matter, brain, and intracranial volumes in first-episode bipolar disorder: a meta-analysis of magnetic resonance imaging studies 146
Association study between HTR2A rs6313 polymorphism and early response to risperidone and olanzapine in schizophrenia patients 146
Brain morphology in first-episode schizophrenia: a meta-analysis of quantitative magnetic resonance imaging studies. 145
Totale 17.959
Salva come PNG Salva come JPEG
Categoria #
all - tutte 264.931
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 264.931
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.868 0 0 0 150 39 124 123 200 136 284 188 624
2022/20233.141 411 30 31 329 246 798 28 366 550 54 153 145
2023/20243.083 207 90 249 209 167 558 109 84 634 81 58 637
2024/20257.512 93 98 144 820 866 631 594 238 893 711 1.569 855
2025/202615.108 1.445 1.983 1.197 1.999 1.371 1.070 2.143 602 844 1.334 710 410
2026/20275.280 761 830 1.353 2.336 0 0 0 0 0 0 0 0
Totale 54.106